Schedule 13G ownership disclosure

ChromaDex Corp.

Security class unavailable · CUSIP: 171077100

Event date: 2015-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-15-002926
Form type
SC 13G
Filer
Niagen Bioscience, Inc.
CIK
CIK 1386570
Filed
Aug 28, 2015
Reporting period
Aug 27, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub